Data-driven modeling of Alzheimer disease pathogenesis.

Area of Science:

• Computational Biology
• Neuroscience
• Systems Biology

Background:

• Alzheimer Disease (AD) is a leading cause of dementia, characterized by complex pathological interactions.
• Existing data on AD pathogenesis is vast but difficult to interpret due to intricate interdependencies.
• The amyloid hypothesis suggests that beta-amyloid accumulation is central to AD development.

Purpose of the Study:

• To develop a computational model of Alzheimer Disease (AD) pathophysiology.
• To represent known facts about AD and analyze their aggregate implications.
• To explore the disruption of beta-amyloid regulation by interacting pathological processes.

Main Methods:

• Development of a computational model using the Maude specification language.
• The model is an executable mathematical theory capable of simulation and logical analysis.
• The model is based on the amyloid hypothesis, focusing on beta-amyloid regulation.

Main Results:

• The model demonstrates how cerebrovascular insufficiency, inflammation, and oxidative stress disrupt beta-amyloid regulation.
• Analysis reveals complex, emergent effects arising from the interaction of various pathological elements.
• Simulations suggest multi-target treatments may be more effective than single-target therapies for reducing beta-amyloid.

Conclusions:

• Computational modeling in Maude is a viable adjunct to experimental research for understanding AD.
• The model provides insights and generates experimentally testable predictions about AD pathogenesis.
• This approach allows for a more comprehensive consideration of relevant biology than traditional methods.